TruAlt Bioenergy Q1 FY27: Total Income Nearly Doubles, PAT Up Over 12x

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

TRUALT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.2%1-day move

₹419.40

prior close

₹450.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4-2.0-2.5-3.0+4.2+0.7+4.4+3.7+10.2+13.7+12.3———

Up moveDown movePending

AI summary

TruAlt Bioenergy posted strong Q1 FY27 results, its first YoY quarterly performance as a listed company. Total Income nearly doubled to ₹641.41 Cr from ₹326.63 Cr, up 96%. EBITDA surged 220% to ₹132.76 Cr. PAT jumped over 12x to ₹78.45 Cr from ₹5.80 Cr. Growth driven by dual-feed ethanol integration, with capacity up 43% to 2,000 KLPD and 65% now on dual-feed. Capacity utilisation at 60.57%. CBG projects with Sumitomo and GAIL are progressing, plus a 100 million litre SAF project backed by a ₹150 Cr government grant.

Likely market impact

Strong revenue and earnings growth signals successful execution of dual-feed strategy. Significant capacity headroom at 60% utilisation supports further upside.